IP Library Assignment 039493/0166
Patent Assignment
Reel/Frame 039493/0166

Change of Name

Recorded: 2016-07-27 Pages: 5
Assignor
OCATA THERAPEUTICS, INC.
Executed: 2016-05-02
Assignee
ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE
33 LOCKE DRIVE, MARLBOROUGH, MASSACHUSETTS, 01752
Covered Properties (34)
Methods For Producing Enriched Populations of Human Retinal Pigment Epithelium Cells
Patent: 9,649,340 →
Application: 12/857,866 →
Publication: US US20110117062A1
Modalities for the treatment of degenerative diseases of the retina
Patent: 9,650,607 →
Application: 13/858,376 →
Publication: US US20130302426A1
Modalities for the treatment of degenerative diseases of the retina
Patent: 9,562,217 →
Application: 13/858,354 →
Publication: US US20130302286A1
Modalities for the treatment of degenerative diseases of the retina
Patent: 9,040,038 →
Application: 13/858,534 →
Publication: US US20130316452A1
Modalities for the treatment of degenerative diseases of the retina
Patent: 9,045,732 →
Application: 13/858,497 →
Publication: US US20130316451A1
Modalities for the Treatment of Degenerative Diseases of the Retina
Patent: 9,040,039 →
Application: 13/865,751 →
Publication: US US20130302288A1
Methods for Producing Enriched Populations of Human Retinal Pigment Epithelium Cells for Treatment of Retinal Degeneration
Patent: 7,794,704 →
Application: 11/041,382 →
Publication: US US20060031951A1
Methods for Producing Enriched Populations of Human Retinal Pigment Epithelium Cells for Treatment of Retinal Degeneration
Patent: 8,268,303 →
Application: 12/857,911 →
Publication: US US20110117063A1
Modalities for the Treatment of Degenerative Diseases of the Retina
Patent: 9,080,150 →
Application: 13/477,763 →
Publication: US US20130022680A1
Methods for Producing Enriched Populations of Human Retinal Pigment Epithelium Cells
Patent: 7,795,025 →
Application: 11/490,953 →
Publication: US US20070031386A1
Modalities for the Treatment of Degenerative Diseases of the Retina
Patent: 9,181,524 →
Application: 14/227,237 →
Publication: US US20140356432A1
Modalities for the Treatment of Degenerative Diseases of the Retina
Patent: 9,193,950 →
Application: 14/227,305 →
Publication: US US20140294779A1
Derivation of Embryonic Stem Cells
Patent: 7,838,727 →
Application: 11/267,555 →
Publication: US US20060206953A1
Derivation of Embryonic Stem Cells
Patent: 9,550,974 →
Application: 14/154,163 →
Publication: US US20140377865A1
Modalities for the Treatment of Degenerative Diseases of the Retina
Patent: 9,040,770 →
Application: 12/781,929 →
Publication: US US20100299765A1
Modalities for the Treatment of Degenerative Diseases of the Retina
Patent: 9,730,962 →
Application: 14/692,191 →
Publication: US US20150328261A1
Blastomere Culture to Produce Mammalian Embryonic Stem Cells
Patent: 8,796,021 →
Application: 12/528,212 →
Publication: US US20100240132A1
Derivation of Embryonic Stem Cells and Embryo-Derived Cells
Patent: 7,893,315 →
Application: 11/800,366 →
Publication: US US20080057041A1
Derivation of Embryonic Stem Cells and Embryo-Derived Cells
Patent: 8,742,200 →
Application: 13/004,260 →
Publication: US US20110183415A1
Derivation of Embryonic Stem Cells and Embryo-Derived Cells
Patent: 9,617,512 →
Application: 14/266,114 →
Publication: US US20140356952A1
Methods of Producing Human Rpe Cells and Pharmaceutical Preparations of Human Rpe Cells
Application: 13/510,426 →
Publication: US US20130149284A1
Pharmaceutical Preparations of Human Rpe Cells and Uses Thereof
Application: 14/713,108 →
Publication: US US20150366915A1
Mesenchymal Stromal Cells and Uses Related Thereto
Patent: 8,962,321 →
Application: 13/691,349 →
Publication: US US20130183272A1
Mesenchymal Stromal Cells and Uses Related Thereto
Application: 14/504,351 →
Publication: US US20160038543A1
Method of Directed Differentiation Producing Corneal Endothelial Cells, Compositions Thereof, and Uses Thereof
Application: 61/567,479 →
Method of Directed Differentiation Producing Corneal Endothelial Cells from Neural Crest Stem Cells by Pdgfb and DKK2, Compositions Thereof, and Uses Thereof
Patent: 9,752,118 →
Application: 14/362,775 →
Publication: US US20140370007A1
Photoreceptors and Photoreceptor Progenitors Produced from Pluripotent Stem Cells
Application: 14/214,598 →
Publication: US US20140294778A1
Mesenchymal Stromal Cells and Uses Related Thereto
Patent: 8,961,956 →
Application: 13/905,526 →
Publication: US US20140072537A1
Mesenchymal Stromal Cells and Uses Related Thereto
Application: 14/629,383 →
Publication: US US20150272994A1
Retinal Ganglion Cells and Progenitors Thereof
Application: 62/046,165 →
Photoreceptors and Photoreceptor Progenitors Produced from Pluripotent Stem Cells
Application: 14/489,415 →
Publication: US US20160175361A1
Methods for Production of Platelets from Pluripotent Stem Cells and Compositions Thereof
Patent: 9,993,503 →
Application: 14/515,619 →
Publication: US US20160022736A1
Assays for Potency of Human Rpe Cells and Photoreceptor Progenitors
Application: 62/136,660 →
Photoreceptors and Photoreceptor Progenitors Produced from Pluripotent Stem Cells
Application: 14/774,771 →
Publication: US US20160030490A1
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement Jan 25, 2013
From: ADVANCED CELL TECHNOLOGY, INC.; MYTOGEN, INC.
To: CAMOFI MASTER LDC; CAMHZN MASTER LDC
Reel/Frame 029698/0001 →
Confirmatory Assignment Aug 6, 2013
From: LANZA, ROBERT
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 030983/0675 →
Assignment of Assignor's Interest Feb 6, 2014
From: LANZA, ROBERT; CHUNG, YOUNG
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 032156/0366 →
Confirmatory Assignment Apr 1, 2014
From: LANZA, ROBERT
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 032589/0047 →
Confirmatory Assignment Apr 1, 2014
From: LANZA, ROBERT
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 032589/0051 →
Assignment of Assignor's Interest Apr 1, 2014
From: KLIMANSKAYA, IRINA V.
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 032577/0210 →
Assignment of Assignor's Interest Apr 1, 2014
From: KLIMANSKAYA, IRINA V.
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 032577/0255 →
Assignment of Assignor's Interest Oct 23, 2014
From: KLIMANSKAYA, IRINA; LANZA, ROBERT
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 034023/0059 →
Assignment of Assignor's Interest Oct 23, 2014
From: KLIMANSKAYA, IRINA V.
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 034023/0115 →
Confirmatory Assignment Oct 23, 2014
From: LANZA, ROBERT
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 034038/0172 →
Assignment of Assignor's Interest Nov 6, 2014
From: CHUNG, YOUNG; LANZA, ROBERT
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 034112/0637 →
Release of Security Interest Nov 24, 2014
From: CAMOFI MASTER LDC; CAMHZN MASTER LDC
To: ADVANCED CELL TECHNOLOGY, INC.; MYTOGEN, INC.
Reel/Frame 034421/0863 →
Confirmatory Assignment Nov 26, 2014
From: LANZA, ROBERT
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 034485/0406 →
Change of Name Jan 7, 2015
From: ADVANCED CELL TECHNOLOGY, INC.
To: OCATA THERAPEUTICS, INC.
Reel/Frame 034749/0622 →
Change of Name Feb 13, 2015
From: ADVANCED CELL TECHNOLOGY, INC.
To: OCATA THERAPEUTICS, INC.
Reel/Frame 034999/0826 →
Change of Name Apr 1, 2015
From: ADVANCED CELL TECHNOLOGY, INC.
To: OCATA THERAPEUTICS, INC.
Reel/Frame 035354/0207 →
Change of Name Aug 18, 2015
From: ADVANCED CELL TECHNOLOGY, INC.
To: OCATA THERAPEUTICS, INC.
Reel/Frame 036378/0266 →
Assignment of Assignor's Interest Aug 18, 2015
From: KLIMANSKAYA, IRINA; LANZA, ROBERT
To: ADVANCED CELL TECHNOLOGY, INC.
Reel/Frame 036345/0644 →
Change of Name Jan 7, 2016
From: ADVANCED CELL TECHNOLOGY, INC.
To: OCATA THERAPEUTICS, INC.
Reel/Frame 037459/0653 →
Change of Name Jan 24, 2016
From: ADVANCED CELL TECHNOLOGY, INC.
To: OCATA THERAPEUTICS, INC.
Reel/Frame 037578/0698 →
Change of Name Jan 24, 2016
From: ADVANCED CELL TECHNOLOGY, INC.
To: OCATA THERAPEUTICS, INC.
Reel/Frame 037578/0683 →
Confirmatory Assignment Apr 5, 2024
From: ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 067024/0057 →